Media, investors, advocacy organizations and others, please contact us here.

In DUPLEX, Patients With Focal Segmental Glomerulosclerosis (FSGS) Reached Low Proteinuria More Often With Sparsentan vs Irbesartan Regardless of Baseline Proteinuria

Page 1 / 1 100%
Loading...